Genetic Engineering News: Breaking Genetic Engineering News, Comments and Articles.

15:25 EDT 7th October 2015 | BioPortfolio

Genetic Engineering NewsRSS

Read the latest Genetic Engineering News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Genetic Engineering.

Search or Follow Our Genetic Engineering News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Genetic Engineering News.

Showing "genetic engineering genetics" News Articles 1 to 25 of 7,300+

Wednesday 7th October 2015

Advanced Medical Isotope Corporation Completes Substantial Capital Restructuring Activities and Continues Product Development

Advanced Medical Isotope Corporation ("AMIC") (OTC Pink:ADMD), a late stage development company engaged in the development of brachytherapy devices for therapeutic applications, today provided the following financial and regulatory update. In the 3rd quarter, AMIC completed a variety of important initiatives that significantly reduced AMIC’s deb...

Enzo Biochem Schedules Teleconference to Discuss Fourth Quarter and Full Year Results Tuesday, October 13, 2015 at 8:30 AM E.T.

Enzo Biochem, Inc. (NYSE:ENZ), will hold a conference call to discuss fiscal 2015 fourth quarter and full year results, Tuesday, October 13, 2015, at 8:30 AM E.T. To listen to the conference call dial 1-888-459-5609. International callers can dial 1-973-321-1024. When prompted, use PIN number 53805533. Dial in approximately ten minutes prio...

Human genetics: Strength in numbers in the low-frequency spectrum

Genetic variation and the de novo assembly of human genomes

The wealth of existing and emerging DNA-sequencing data provides an opportunity for a comprehensive understanding of human genetic variation, including the discovery of disease-causing variants. This Review describes how the limitations of current re...

Developing an intervention to facilitate family communication about inherited genetic conditions, and training genetic counsellors in its delivery

CORRECTING and REPLACING Proteintech and Cell, Neuron Announce Winners of Neuroscience Travel Grants

“Synthetic molecular antibodies” and calcium imaging of cortical activity receive $1,000 stipends Eighth paragraph of release dated September 30, 2015 should be removed. The corrected release reads: PROTEINTECH AND CELL, NEURON ANNOUNCE WINNERS OF NEUROSCIENCE TRAVEL GRANTS “Synthetic molecular antibodies” and ...

Australian High Court rules to disallow patenting of isolated genetic materials

The Australian High Court has ruled to disallow patenting of isolated genetic materials.

Marathon Pharmaceuticals Receives Rare Pediatric Disease Designation from FDA for Deflazacort as a Potential Treatment of Duchenne Muscular Dystrophy

Marathon Pharmaceuticals, a biopharmaceutical company that develops new treatments for rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted rare pediatric disease designation for deflazacort, a potential treatment for patients with Duchenne muscular dystrophy (DMD). The rare pediatric disease designation supp...

Agilent Technologies Shares Vision for Precision Genomics at ASHG 2015

Agilent Technologies Inc. (NYSE:A) is sharing its vision for precision medicine this week at the annual meeting of the American Society of Human Genomics. The conference, held in Baltimore, Maryland, is a forum for discussing recent advances in all areas of human genetics. “As new technologies and greater understanding of the causes and pathways...

Genetic Defences of Bacteria Don’t Aid Antibiotic Resistance

Genetic responses to the stresses caused by antibiotics don’t help bacteria to evolve a resistance to the medications, according to a new study by Oxford University researchers.Read more about Genetic Defences of Bacteria Don’t Aid Antibiotic Res...

The cells’ toolbox for DNA repair

The Nobel Prize in Chemistry 2015 is awarded to Tomas Lindahl, Paul Modrich and Aziz Sancar for having mapped, at a molecular level, how cells repair damaged DNA and safeguard the genetic information. Their work has provided fundamental knowledge of...

The cells’ toolbox for DNA repair: Nobel prize

The Nobel Prize in Chemistry 2015 is awarded to Tomas Lindahl, Paul Modrich and Aziz Sancar for having mapped, at a molecular level, how cells repair damaged DNA and safeguard the genetic information. Their work has provided fundamental knowledge of...

'Chromosomal Chaos:' Complex array of mutations found in rare, aggressive leukemia

Sezary syndrome (SS), an aggressive leukemia of mature T cells, is more complicated at a molecular level than ever suspected, according to investigators from the Perelman School of Medicine at the University of Pennsylvania. With a poor prognosis and...

Shaking up the foundamentals of epigenetics

Cells of multicellular organisms contain identical genetic material (the genome) yet can have drastic differences in their structural arrangements and functions. This variation of the distinct cell types comes from the differential expression of gene...

Counsyl Reaches 500,000 Patients Screened, Doubles Patients Served in Just Over One Year

Counsyl’s genetic counselors have logged more than 10,000 hours of counseling, illustrating growing demand for genetic screening and access to genetic counseling services to better understand results Counsyl, a health technology company that offers DNA screening for diseases that can impact women, men, and their children, announced today t

NIH Awards City of Hope $2.2 Million Grant for Study of Diabetes, Epigenetics

Researchers hope to ultimately identify window of intervention for diabetes complications The National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health has awarded a $2.2 million grant to help City of Hope researchers expand their knowle

Invitae Expands Its Neuromuscular Offering with Broad, Affordable Panels and New Testing Categories for Patients

-- Now offering high-quality, affordable genetic tests for Duchenne/Becker muscular dystrophy, dystonia, and expanded panels for Charcot-Marie-Tooth disease and hereditary spastic paraplegia -- Invitae Corporation

Invitae Expands Its Offering for Rare Disease and Pediatric Conditions with Broader, Affordable Genetic Tests

-- High-quality genetic tests now available for RASopathies, ciliopathies, and various congenital structural heart defects, patient pay price is $475 -- -- More panels for rare diseases to be introduced in coming months -- nvitae Corporation

Invitae Expands Its Cardiology Offering to Provide More Comprehensive Testing for Patients and Their Families

-- A wide range of high-quality, affordable genetic tests now available for hereditary cardiovascular disorders -- Invitae Corporation (NYSE: NVTA), a genetic information company, today announced the expansion of its card

Invitae Expands Its Hereditary Cancer Offering

-- Now offering new high-quality panels for gastric cancer, for common hereditary cancer, and for expanded breast, gynecologic, colon, and pancreatic cancer testing -- Invitae Corporation

Helping patients with movement disorders regain control of their lives

SUGAR LAND, Texas, Oct. 7, 2015 /PRNewswire-USNewswire/ -- Movement — even something as basic as picking up a piece of paper— appears to be simple to most people, but is actually a complex process.  It requires several different parts of the brain to work together with many muscle groups. "There are continuous to and from communications between the brain, muscles...

Seattle Genetics Announces Initiation of Phase 1/2 Clinical Trial of ADCETRIS® (Brentuximab Vedotin) in Combination with Opdivo® (Nivolumab) in Second-line Hodgkin Lymphoma

-First of Two Planned Trials Combining ADCETRIS and Opdivo Under Clinical Collaboration Agreement with Bristol-Myers Squibb- Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that it has initiated a phase 1/2 clinical trial of

Growth Fund Invests in Science Park Companies

Two businesses have secured investment from the Corridor Growth Fund (CGF) to expand their operations at Manchester Science Park (MSP).The £2m Manchester City Council-managed fund is awarding investments to Veraz Ltd and Elucigene Diagnostic...

Genocea Announces Positive Durability Data from 6-Month Analysis of Phase 2 Clinical Trial of Genital Herpes Immunotherapy GEN-003

- Sustained viral shedding rate reduction of 58 percent from baseline at best dose improves upon established attractive product profile - - Efficacy seen consistently across several potential Phase 3 clinical endpoints - - End of Phase 2 meeting with FDA expected in late 2016 - - Company to host conference call at 9 a.m. ET toda...

Invitae Expands Test Menu to Include Hundreds of New Genes, Dozens of New Test Panels for Cancer, Cardiology, Neuromuscular, Pediatrics, and Rare Disorders

-- Company announces it exceeded its goal with more than 600 genes in production, commercially launching new panels immediately and throughout the end of 2015 -- -- Hosting an investor conference call today at 4:30 p.m. ET -- Invitae Corporation


News Quicklinks